Regeneron drug prevents symptomatic Covid-19 by 81% – With insights from The Wall Street Journal
Regeneron ‘says it will ask federal health regulators to clear use among people who haven’t been vaccinated’, reports The Wall Street Journal.
BizNews Health covers cutting-edge research, advances, opinions and debates in medicine, health and wellbeing from orthodox, complementary and alternative perspectives. We have a special focus on nutrition, fitness, longevity medicine, and prevention of non-communicable diseases – such as obesity, cancer, type 2 diabetes, heart disease and stroke, increasingly mood disorders such as depression, and dementias. We include lifestyle and travel to healthy destinations, since mind and body are integrally connected, and optimum health is not just the absence of disease, but a state of complete physical, mental, and even spiritual wellbeing.
Regeneron ‘says it will ask federal health regulators to clear use among people who haven’t been vaccinated’, reports The Wall Street Journal.
European regulator finds link to rare blood clots but says vaccine’s benefits still outweigh risks, reports The Wall Street Journal.
I think that whoever made the decision [to not use the AstraZeneca shot in SA] was extremely short-sighted and stupid, says Prof Alan Whiteside.
Vaccinating children will likely be necessary to reach herd immunity, experts say, but vaccines aren’t authorized for kids yet.
The drug was effective at a higher dose already in use and a lower dose, which the company said it would seek permission to start selling.
Germany, France and Italy have joined other countries ‘in pausing shots after a small number of cases of blood clotting on the continent’.
‘Health officials in the city also are studying another strain, first detected in late November’, reports The Wall Street Journal.
Professor Eli Schwartz says he has new proof that Ivermectin could help reduce the length of infection for people who contract coronavirus.
‘One shot of Pfizer-BioNTech vaccine reduced cases among elderly and healthcare workers, according to data from rollout’, reports The Wall Street Journal.
In this episode, we speak to 32-year-old researcher Sandile Cele who has made global headlines for an important breakthrough in the fight against Covid-19.